Minichromosome Maintenance Complex Is a Critical Node in the miR-183 Signaling Network of MYCN-Amplified Neuroblastoma Cells

被引:6
|
作者
Lodrini, Marco [1 ]
Poschmann, Gereon [2 ]
Schmidt, Victoria [3 ,4 ]
Wuenschel, Jasmin [1 ]
Dreidax, Daniel [5 ]
Witt, Olaf [3 ,4 ,6 ,7 ]
Hoefer, Thomas [8 ]
Meyer, Helmut E. [9 ]
Stuehler, Kai [2 ,10 ]
Eggert, Angelika [1 ]
Deubzer, Hedwig E. [1 ,3 ,4 ,6 ,7 ,11 ,12 ]
机构
[1] Charite, Campus Virchow Klinikum, Dept Pediat Hematol Oncol Stem Cell Transplantat, Augustenburger Pl 1, D-13353 Berlin, Germany
[2] Univ Dusseldorf, Biol Med Res Ctr, Mol Prote Lab, Univ Str 1, D-40225 Dusseldorf, Germany
[3] German Canc Res Ctr, Clin Cooperat Unit Pediat Oncol, INF 280, D-69120 Heidelberg, Germany
[4] German Consortium Translat Canc Res DKTK, INF 280, D-69120 Heidelberg, Germany
[5] DKFZ, Div Neuroblastoma Genet, INF 280, D-69120 Heidelberg, Germany
[6] Heidelberg Univ, Dept Pediat Hematol Oncol, Ctr Individualized Pediat Oncol ZIPO & Brain Tumo, INF 430, D-69120 Heidelberg, Germany
[7] Natl Ctr Tumor Dis NCT, INF 430, D-69120 Heidelberg, Germany
[8] DKFZ, Div Theoret Syst Biol, INF 280, D-69120 Heidelberg, Germany
[9] Leibniz Inst Analyt Wissensch ISAS eV, Bunsen Kirchhoff Str 11, D-44139 Dortmund, Germany
[10] Univ Hosp Dusseldorf, Inst Mol Med, Univ Str 1, D-40225 Dusseldorf, Germany
[11] Max Delbruck Ctr Mol Med, Expt & Clin Res Ctr, Jr Neuroblastoma Res Grp, Lindenberger Weg 80, D-13125 Berlin, Germany
[12] Charite, Lindenberger Weg 80, D-13125 Berlin, Germany
关键词
cell cycle progression; eukaryotic genome replication; genomic integrity; label-free proteomics; dual-luciferase reporter gene assay; oncogene; systems biology; MICRORNA BINDING-SITES; DOWN-REGULATION; ABERRANT EXPRESSION; TISSUE MICROARRAY; COLORECTAL-CANCER; PROTEIN MCM7; MARKER; IDENTIFICATION; PROLIFERATION; PROGNOSIS;
D O I
10.1021/acs.jproteome.6b00134
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
MYCN and HDAC2 jointly repress the transcription of tumor suppressive miR-183 in neuroblastoma. Enforced miR-183 expression induces neuroblastoma cell death and inhibits xenograft growth in mice. Here we aimed to focus more closely on the miR-183 signaling network using a label-free mass spectrometric approach. Analysis of neuroblastoma cells transfected with either control or miR-183 expression vectors identified 85 differentially expressed proteins. All six members of the minichromosome maintenance (MCM) complex, which is indispensable for initiation and elongation during DNA replication and transcriptionally activated by MYCN in neuroblastoma, emerged to be down-regulated by miR-183. Subsequent annotation category enrichment analysis revealed a similar to 14-fold enrichment in the "MCM" protein module category, which highlighted this complex as a critical node in the miR-183 signaling network. Down-regulation was confirmed by Western blotting. MCMs 2-5 were predicted by in silico methods as direct miR-183 targets. Dual-luciferase reporter gene assays with 3'-UTR constructs of the randomly selected MCMs 3 and 5 experimentally confirmed them as direct targets of miR-183. Our results reveal the MCM complex to be a critical and directly regulated node within the miR-183 signaling network in MYCN-amplified neuroblastoma cells.
引用
收藏
页码:2178 / 2186
页数:9
相关论文
共 6 条
  • [1] MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma
    Lodrini, Marco
    Oehme, Ina
    Schroeder, Christina
    Milde, Till
    Schier, Marie C.
    Kopp-Schneider, Annette
    Schulte, Johannes H.
    Fischer, Matthias
    De Preter, Katleen
    Pattyn, Filip
    Castoldi, Mirco
    Muckenthaler, Martina U.
    Kulozik, Andreas E.
    Westermann, Frank
    Witt, Olaf
    Deubzer, Hedwig E.
    NUCLEIC ACIDS RESEARCH, 2013, 41 (12) : 6018 - 6033
  • [2] RETRACTION: Targeting MYCN IRES in MYCN-amplified Neuroblastoma With Mir-375 Inhibits Tumor Growth and Sensitizes Tumor Cells to Radiation
    Zhang, H.
    Liu, T.
    Yi, S.
    Gu, L.
    Zhou, M.
    MOLECULAR ONCOLOGY, 2025, 19 (01) : 261 - 261
  • [3] MYCN-amplified neuroblastoma cell-derived exosomal miR-17-5p promotes proliferation and migration of non-MYCN amplified cells
    Chen, Weiming
    Hao, Xiwei
    Yang, Binyi
    Zhang, Yuezhen
    Sun, Lingyun
    Hua, Yanan
    Yang, Li
    Yu, Jiabin
    Zhao, Jing
    Hou, Lin
    Lu, Hongting
    MOLECULAR MEDICINE REPORTS, 2021, 23 (04)
  • [4] MYCN-amplified neuroblastoma cell-derived exosomal miR-17-5p promotes proliferation and migration of non-MYCN amplified cells (vol 23, 245, 2021)
    Chen, Weiming
    Hao, Xiwei
    Yang, Binyi
    Zhang, Yuezhen
    Sun, Lingyun
    Hua, Yanan
    Yang, Li
    Yu, Jiabin
    Zhao, Jing
    Hou, Lin
    Lu, Hongting
    MOLECULAR MEDICINE REPORTS, 2024, 30 (06)
  • [5] RETRACTED: Targeting MYCN IRES in MYCN-amplified neuroblastoma with miR-375 inhibits tumor growth and sensitizes tumor cells to radiation (Retracted article. See vol. 19, pg. 261, 2025)
    Zhang, Hailong
    Liu, Tao
    Yi, Sha
    Gu, Lubing
    Zhou, Muxiang
    MOLECULAR ONCOLOGY, 2015, 9 (07) : 1301 - 1311
  • [6] Combined IFN-γ and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in MYCN-amplified neuroblastoma cells
    Cetinkaya, Cihan
    Hultquist, Anne
    Su, Yingtao
    Wu, Siqin
    Bahram, Fuad
    Pahlman, Sven
    Guzhova, Irina
    Larsson, Lars-Gunnar
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (10) : 2634 - 2641